Intraperitoneal injection induces a delayed preconditioning-like effect in mice.
We hypothesized that intraperitoneal injections of anaesthetics or fluid per se might evoke a delayed preconditioning-like response in mice hearts isolated and Langendorff perfused 24 h later. To test this, mice were given opioid anaesthesia by intraperitoneal injections or sham treated and the hearts were harvested and subjected to global ischaemia and reperfusion 24 h later in series 1. In series 2, mice were subjected to intraperitoneal injection of Ringer, sham needle prick procedure, or no intervention 24 h before heart isolation. In series 3, intraperitoneal Ringer injection 24 h earlier was compared with the effects of classic preconditioning or no pretreatment of the isolated heart or no treatment. Heart function was measured in all series. At the end of reperfusion, hearts in series 1 and 2 were frozen and infarct size was estimated by triphenyltetrazolium chloride solution. In series 3, separate hearts were frozen for immunoblotting to detect phosphorylation of mitogen-activated protein (MAP) kinases. Cardiac activation of nuclear factor kappa B (NFkappaB) was measured using a NFkappaB luciferase firefly reporter mouse. The ischaemia-induced impairment of left ventricular function was attenuated by opioid anaesthesia injected 24 h earlier, which also reduced infarct size. Injection of fluid, but not the sham needle prick procedure, reduced infarct size. The functional protection afforded by classic preconditioning and Ringer pretreatment was comparable. Neither cardiac MAP kinases nor NFkappaB were influenced by the interventions. In conclusion, this study demonstrates a delayed preconditioning-like effect of the heart caused by intraperitoneal administration of opioid anaesthetics and of fluid only in the mouse. The mechanism of protection remains to be determined.
Labruto
Fausto
F
Crafoord Laboratory for Experimental Surgery, Karolinska Institute, Stockholm, Sweden. lampo18@yahoo.com
Vaage
Jarle
J
Li
Guohu
G
Valen
Guro
G
D000704:Analysis of Variance; D000777:Anesthetics / Q000008:administration & dosage* / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure; D006321:Heart / Q000187:drug effects*; D015151:Immunoblotting; D007274:Injections, Intraperitoneal; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods*; D008156:Luciferases; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009203:Myocardial Infarction / Q000473:pathology*; D017202:Myocardial Ischemia; D015425:Myocardial Reperfusion; D016328:NF-kappa B / Q000378:metabolism; D010766:Phosphorylation; D013778:Tetrazolium Salts
D000777:Anesthetics; D016328:NF-kappa B; D013778:Tetrazolium Salts; C009591:triphenyltetrazolium; D008156:Luciferases; D020928:Mitogen-Activated Protein Kinases